Sleep in Patients With Multiple Sclerosis

Abstract

Sleep disorders are highly prevalent and consequential comorbidities among patients with multiple sclerosis (MS) yet remain notably under-recognized in clinical practice. Improved understanding of the specific clinical features of MS that may influence patients’ risk for sleep disturbances or response to treatment could enhance opportunities to improve functional status and quality of life in persons with MS. This review aims to discuss current prevalence estimates, disease-specific risk factors, and consequences of the most common sleep disorders experienced by patients with multiple sclerosis. Suggested methods to address MS-specific symptoms and comorbidities that may influence diagnostic and treatment strategies for these conditions are also highlighted.